← Eichor
Study identifier: NCT06314607 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Genetic and Molecular Characterization of Nervous System Lesions

Condition: Brain Tumor · Brain Lesion (General)  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Primary and secondary brain tumors, the leading cause of death from cancer before the age of 35, represent a complex and heterogeneous group of pathologies with a generally poor prognosis. Knowledge of these tumors has made enormous strides thanks to access to biological samples, leading to a much more robust, reliable and precise histo-pronostic classification, but also, increasingly, to the identification of theranostic targets. Despite these advances, there is a real need to refine diagnostic and prognostic classification, identify the biological mechanisms involved in the formation and progression of these pathologies, develop new targeted strategies, and devise minimally invasive follow-up methods (liquid biopsies). In addition, certain non-tumoral brain lesions (e.g. malformations) can be similarly classified according to their molecular and mutational profile. This project aims to make a decisive contribution to these objectives.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Sanson, Prof  ·  01 42 16 03 91  ·  marc.sanson@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Service de Neurochirurgie - Hôpital de la Pitié SalpêtrièreParis, FranceRecruiting
Service de Neurologie 2 -Hôpital de la Pitié SalpêtrièreParis, FranceRecruiting
Service de Radiothérapie - Hôpital de la Pittié SalpêtrièreParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06314607